Analgesic patches and defibrillators: A cautionary tale

Europace

Volumn 11, Issue 11, 2009, Pages 1552-1553

  Brown, Martin R ^a   Denman, Russell ^a   Platts, David ^a  

^a THE PRINCE CHARLES HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; NORSPAN; UNCLASSIFIED DRUG;

AGED; ANALGESIA; ARTICLE; BURN; CARDIOVERSION; CASE REPORT; CHRONIC PAIN; DEFIBRILLATION; DEFIBRILLATOR; DERMIS; DRUG DELIVERY SYSTEM; HEART FAILURE; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTATION; MALE; PATIENT EDUCATION; PRIORITY JOURNAL; THORAX PAIN; THORAX RADIOGRAPHY;

AGED; ANALGESICS, OPIOID; BANDAGES; BUPRENORPHINE; BURNS, ELECTRIC; DEFIBRILLATORS, IMPLANTABLE; HUMANS; MALE; SKIN;

EID: 71049159528     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eup261     Document Type: Article

References (5)

1. Murphy M, Carmichael A. Transdermal drug delivery systems and skin sensitivity reactions: Incidence and management. Am J Clin Dermatol 2000;1:361-368
2. Staskin DR. Transdermal systems for overactive bladder: Principles and practice. Rev Urol 2003;5:S26-30.
3. Anonymous. Aluminium containing transdermal patches: A risk of burns. Prescrire Int 2007;16:246.
4. Karch A. Don't get burnt by the MRI; transdermal patches can be a hazard to patients. Am J Nurs 2004;104:31.
5. Morrison PR, Brown SD, vanSonnenberg E. Pediatric return electrodes for radiofrequency ablation in children. Am J Roentgenol 2004;185:84-85